Advertisement
Canada markets open in 1 hour 52 minutes
  • S&P/TSX

    21,837.18
    -12.02 (-0.06%)
     
  • S&P 500

    5,149.42
    +32.33 (+0.63%)
     
  • DOW

    38,790.43
    +75.63 (+0.20%)
     
  • CAD/USD

    0.7369
    -0.0020 (-0.27%)
     
  • CRUDE OIL

    82.71
    -0.01 (-0.01%)
     
  • Bitcoin CAD

    85,417.61
    -7,392.82 (-7.97%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,158.20
    -6.10 (-0.28%)
     
  • RUSSELL 2000

    2,024.74
    -14.58 (-0.72%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • NASDAQ futures

    18,131.25
    -100.25 (-0.55%)
     
  • VOLATILITY

    14.79
    +0.46 (+3.21%)
     
  • FTSE

    7,704.05
    -18.50 (-0.24%)
     
  • NIKKEI 225

    40,003.60
    +263.20 (+0.66%)
     
  • CAD/EUR

    0.6792
    0.0000 (0.00%)
     

Stocks get oil boost; Goodbye, Sumner Redstone; Shkreli's silence

Stocks (^DJI^GSPC^IXIC) are getting a boost today from oil (OIL), which is adding to its big gains from yesterday.

To discuss that and some of the other big stories of the day are Yahoo Finance's Alexis Christophorous, Yahoo Finance columnist Rick Newman and Mark Martiak, vice president, senior wealth strategist at Premier Wealth First Allied Securities.

Sumner Redstone's exit

A media titan is stepping down. The 92-year-old Sumner Redstone officially resigned as executive chairman of CBS (CBS) on Wednesday, and the Viacom (VIA) board is reportedly meeting today to discuss options.

Wall Street and the 2016 election

It's just five days to the first-in-the-nation primary in New Hampshire, and Democratic presidential candidates Hillary Clinton and Bernie Sanders are continuing to spar over who will be tougher on Wall Street ahead of tonight's debate in the Granite State. Meanwhile, on the Republican side, Donald Trump and Ted Cruz are questioning loans each received from big financial firms. But Newman says the financial markets will NOT be significantly affected by which candidate gets elected.

ADVERTISEMENT

Shkreli on Capitol Hill

It was "must-see TV" for financial news junkies today. Disgraced former pharmaceutical CEO Martin Shkreli got grilled by a House committee over his move to hike the price of a treatment for a rare disease by more than 5,000%. Shkreli's facial expressions showed distain as he refused to answer the panel's questions, and he later tweeted: "Hard to accept that these imbeciles represent the people in our government."